Clinical Trial Update: Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing tigecycline to imipenem/cilastatin in hospitalized patients with complicated intra-abdominal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• Imipenem/Cilastatin (imipenem/cilastatin)
• Tigecycline (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gram-Positive Bacterial Infections, Cross Infection | Phase 3 | Status: COMPLETED